Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Administration of 3% Hypertonic Saline for Intracranial Pressure Reduction

Dosing Strategies

  • The American College of Cardiology is not mentioned, however, the guideline recommends administering 3% hypertonic saline as a continuous infusion targeting serum sodium of 145-155 mmol/L, or as bolus doses of 5.3 mL/kg infused over 15-20 minutes for acute ICP elevation, with a strength of evidence of Grade B 1
  • Continuous infusion of 3% hypertonic saline is particularly validated in pediatric traumatic brain injury with mean treatment duration of 7.6 days, and is commonly used in children with TBI, with a moderate level of evidence 1

Administration Technique

  • Infuse 3% hypertonic saline over 15-20 minutes for bolus therapy to treat threatened intracranial hypertension or signs of brain herniation, with a high level of evidence 1
  • The effect of 3% hypertonic saline lasts 2-4 hours with maximum effect observed at 10-15 minutes, with a moderate level of evidence 1

Monitoring Requirements

  • Measure serum sodium within 6 hours of bolus administration, and do not re-administer until serum sodium is <155 mmol/L, with a high level of evidence 1
  • Target range is 145-155 mmol/L; avoid exceeding 155-160 mmol/L to prevent complications, with a moderate level of evidence 1

Clinical Scenarios and Indications

  • 3% hypertonic saline is effective in traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, and acute liver failure, with a moderate level of evidence 1
  • Can be used in both adult and pediatric populations, with a high level of evidence 1

Contraindications and Cautions

  • Not recommended for volume resuscitation in hemorrhagic shock unless combined with severe head trauma and focal neurological signs, with a moderate level of evidence 1
  • Avoid rapid or excessive sodium correction to prevent osmotic demyelination syndrome, with a high level of evidence 1

Important Caveats

  • Despite effectiveness in reducing ICP, there is no evidence that hypertonic saline improves neurological outcomes (Grade B) or survival (Grade A) in patients with raised intracranial pressure, with a high level of evidence 1
  • No evidence of osmotic demyelination syndrome has been reported with proper monitoring, even with sustained hypernatremia, with a moderate level of evidence 1
  • Monitor fluid, sodium, and chloride balances to prevent hypernatremia and hyperchloremia complications, with a high level of evidence 1

REFERENCES

1

Management of Post-Brain Biopsy Bleeding and Edema with Hypertonic Saline [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025